Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline - - Interim Phase 1b proof-of-concept data, including initial efficacy ...
Arcadia Biosciences (NASDAQ:RKDA) is scheduled to announce Q4 earnings results on Thursday, March 20th, after market close. The consensus EPS Estimate is -$0.89 (+57.6% Y/Y) and the consensus Revenue ...
Roth MKM analyst Jason Wittes raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the ...
Analysts Conflicted on These Healthcare Names: Hyperfine (HYPR) and Monogram Orthopaedics Inc (MGRM)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hyperfine (HYPR – Research Report) and Monogram Orthopaedics ...
Stock analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics ...
Analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Monogram Orthopaedics in a ...
MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th ...
Approximately 100 residents showed up at the Firefighters Activity Center Tuesday night to participate in a community town hall and hear updates about Shippensburg’s future. Moderated by Chamber of ...
NEW YORK--(BUSINESS WIRE)--MFA Financial, Inc. (NYSE: MFA) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.36 per share of common stock, an ...
Monogram International is bringing its A-game and new licensed foam bag clips and other collectibles to Toy Fair this weekend. The company features a wide selection of licensed, with upcoming launches ...
The company also outperformed in earnings per share, reporting $0.89 adjusted, higher than the expected $0.84. For the first quarter of fiscal 2025, Nvidia anticipates revenue of $43 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results